← FDA Drug Approvals (Drugs@FDA)
TACROLIMUS
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CONCORD BIOTECH LTD · Approved 2020-11-10
Drug application
- FDA Application #
ANDA213112- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- TACROLIMUS
- Generic name
- TACROLIMUS
- Active ingredients
- TACROLIMUS
- Dosage form
- CAPSULE
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- CONCORD BIOTECH LTD
- Manufacturer
- Stellon Biotech Inc.
- First approval
- 2020-11-10
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown